Lifeworks Advisors LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lifeworks Advisors LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 426 shares of the medical equipment provider’s stock, valued at approximately $222,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Massachusetts Financial Services Co. MA purchased a new position in Intuitive Surgical in the third quarter worth approximately $558,807,000. Proficio Capital Partners LLC lifted its stake in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares during the last quarter. FMR LLC grew its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $313,769,000. Finally, Wilmington Savings Fund Society FSB increased its position in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on ISRG shares. UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Piper Sandler restated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Finally, BTIG Research boosted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

View Our Latest Research Report on ISRG

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 489 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $533.18, for a total value of $260,725.02. Following the transaction, the senior vice president now directly owns 2,091 shares in the company, valued at $1,114,879.38. This represents a 18.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,579 shares of company stock valued at $7,756,844 over the last quarter. 0.90% of the stock is owned by insiders.

Intuitive Surgical Trading Down 3.8 %

Shares of ISRG opened at $518.26 on Monday. The firm has a market capitalization of $184.59 billion, a price-to-earnings ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43. The firm’s fifty day simple moving average is $571.36 and its 200-day simple moving average is $531.85. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.